Poveda E - Search Results

1

No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients.

Di Lello FA, Macias J, Plaza Z, García-Rey S, Soriano V, Cifuentes C, González Mdel M, Parra-Sánchez M, Labarga P, Recio E, Poveda E, Pineda JA. Di Lello FA, et al. Among authors: poveda e. Antiviral Res. 2012 Aug;95(2):67-71. doi: 10.1016/j.antiviral.2012.05.016. Epub 2012 Jun 7. Antiviral Res. 2012. PMID: 22683722

2

[HIV entry into the cells--mechanisms and therapeutic possibilities].

Briz V, Poveda E, Soriano V. Briz V, et al. Among authors: poveda e. Med Clin (Barc). 2006 Mar 11;126(9):341-8. doi: 10.1157/13085735. Med Clin (Barc). 2006. PMID: 16650368 Free PMC article. Review. Spanish.

3

Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors.

Poveda E, Blanco F, García-Gascó P, Alcolea A, Briz V, Soriano V. Poveda E, et al. AIDS. 2006 Jul 13;20(11):1558-60. doi: 10.1097/01.aids.0000237375.23692.f4. AIDS. 2006. PMID: 16847414

4

Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy.

Poveda E, Briz V, de Mendoza C, Benito JM, Corral A, Zahonero N, Lozano S, González-Lahoz J, Soriano V. Poveda E, et al. J Med Virol. 2007 Aug;79(8):1040-6. doi: 10.1002/jmv.20900. J Med Virol. 2007. PMID: 17596837

5

Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years.

Briz V, Poveda E, del Mar González M, Martín-Carbonero L, González-González R, Soriano V. Briz V, et al. Among authors: poveda e. J Antimicrob Chemother. 2008 Feb;61(2):405-10. doi: 10.1093/jac/dkm469. Epub 2007 Dec 6. J Antimicrob Chemother. 2008. PMID: 18063598

6

Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years.

Briz V, Poveda E, López M, González Mdel M, Soriano V, Benito JM. Briz V, et al. Among authors: poveda e. AIDS. 2008 Jul 11;22(11):1371-4. doi: 10.1097/QAD.0b013e3283018504. AIDS. 2008. PMID: 18580618

7

Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues.

Poveda E, de Mendoza C, Pattery T, González Mdel M, Villacian J, Soriano V. Poveda E, et al. AIDS. 2008 Nov 12;22(17):2395-8. doi: 10.1097/QAD.0b013e32831692fb. AIDS. 2008. PMID: 18981781

8

[Pharmacokinetics, interactions and mechanism of action of maraviroc].

Soriano V, Poveda E. Soriano V, et al. Among authors: poveda e. Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 11:12-6. doi: 10.1016/s0213-005x(08)76558-3. Enferm Infecc Microbiol Clin. 2008. PMID: 19133216 Review. Spanish.

9

Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.

Poveda E, Seclén E, González Mdel M, García F, Chueca N, Aguilera A, Rodríguez JJ, González-Lahoz J, Soriano V. Poveda E, et al. J Antimicrob Chemother. 2009 May;63(5):1006-10. doi: 10.1093/jac/dkp063. Epub 2009 Mar 3. J Antimicrob Chemother. 2009. PMID: 19261623

10

Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools.

Chueca N, Garrido C, Alvarez M, Poveda E, de Dios Luna J, Zahonero N, Hernández-Quero J, Soriano V, Maroto C, de Mendoza C, García F. Chueca N, et al. Among authors: poveda e. J Med Virol. 2009 May;81(5):763-7. doi: 10.1002/jmv.21425. J Med Virol. 2009. PMID: 19319937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters